___

• • Al-Soud, Y. A., Al-Dweri, M. N., & Al-Masoudi, N. A. (2004). Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. Farmaco, 59(10), 775–783.
• • Boraei, A. T. A., Singh, P. K., Sechi, M., & Satta, S. (2019). Discovery of novel functionalized 1,2,4-triazoles as PARP-1 inhibitors in breast cancer: Design, synthesis and antitumor activity evaluation. European Journal of Medicinal Chemistry, 182, 111621.
• • Çapan, G., Ergenç, N., & Ötük, G. (1990-92). Synthesis and biological evaluation of 4-alkyl/aryl-1-(2-furoyl)-3-thiosemicarbazides and 4-alkyl/aryl-2,4-dihydro-5-(2-furyl)-3H-1,2,4-triazole-3-thiones. Journal of Faculty of Pharmacy of Istanbul, 26-28, 23–30.
• • Çapan, G., Ergenç, N., & Ötük, G. (1993). Synthesis, characterization and biological evaluation of 1,2,4-triazole-3-mercaptoacetic acid derivatives. Acta Pharmaceutica Turcica, 35, 51–58.
• • Çapan, G., Ulusoy, N., Ergenç, N., & Kiraz, M. (1999). New 6-phenylimidazo[2,1-b]thiazole derivatives: Synthesis and antifungal activity. Monatshefte fur Chemie, 130(11), 1399–1407.
• • Demirbaş, N., Karaoğlu, S. A., Demirbaş, A., & Sancak, K. (2004). Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4] thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4] triazol-3-yl)methyl-5-oxo-[1,2,4]triazole derivatives. European Journal of Medicinal Chemistry, 39(9), 793-804.
• • Dimmock, J. R., Vashishtha, S. C., & Stables, J. P. (2000). Anticonvulsant properties of various acetylhydrazones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds. European Journal of Medicinal Chemistry, 35(2), 241–248.
• • El-Sherief, H. A. M., Youssif, B. G. M., Abbas Bukhari, S. N., Abdelazeem, A. H., Abdel-Aziz, M., & Abdel-Rahman, H. M. (2018). Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors. European Journal of Medicinal Chemistry, 156, 774–789.
• • Ergenç, N., Ulusoy, N., Çapan, G., Sanis, G. Ö., & Kiraz, M. (1996). Synthesis and antimicrobial properties of new 4-(alkylidene/ arylidene)-amino-5-(2-furanyl)-2,4-dihydro-3H-1,2,4-triazole-3thiones and 6-aryl-3-(2-furanyl)-7H-1,2,4-triazolo[3,4-b][1,3,4] thiadiazines. Archiv der Pharmazie, 329(8–9), 427–430.
• • Fernández-Torres, B., Cabañes, F. J., Carrillo-Muñoz, A. J., Esteban, A., Inza, I., Abarca, L., & Guarro, J. (2002). Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. Journal of Clinical Microbiology, 40(11), 3999–4003.
• • Günay, N. S., Çapan, G., Ulusoy, N., Ergenç, N., Ötük, G., & Kaya, D. (1999). 5-Nitroimidazole derivatives as possible antibacterial and antifungal agents. Farmaco, 54(11-12), 826–831.
• • Holla, S., B., Veerendra, B., Shivananda, M. K., & Poojary, B. (2003). Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. European Journal of Medicinal Chemistry, 38(7-8), 759–767.
• • İlhan, E. Ergenç, N., Ulusoy, N., & Ötük Sanış, G., (1996). Synthese und antimikrobielle Untersuchung einiger 4-Arylidenamino-3(α,α-diphenyl-α-hydroxymethyl)-1,4-dihydro-5H-1,2,4-Triazol5-thione und 6-Aryl-3-(α,α-diphenyl-α-hydroxymethyl)-7H-sTriazolo[3,4-b][1,3,4]thiadiazine. Die Pharmazie, 51(2), 123–124.
• • Imramovský, A., Polanc, S., Vinšová, J., Kočevar, M., Jampílek, J., Rečková, Z., & Kaustová, J. (2007). A new modification of antitubercular active molecules. Bioorganic and Medicinal Chemistry, 15(7), 2551–2559.
• • Koçyiğit Kaymakçıoğlu, B., Oruç, E., Ünsalan, S., Kandemirli, F., Shvets, N., Rollas, S., & Dimoglo, A. (2006). Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity. European Journal of Medicinal Chemistry, 41(11), 1253–1261.
• • Mustafa, M., Abdelhamid, D., Abdelhafez, E. S. M. N., Ibrahim, M. A. A., Gamal-Eldeen, A. M., & Aly, O. M. (2017). Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues. European Journal of Medicinal Chemistry, 141, 293–305.
• • Mustafa, M., Anwar, S., Elgamal, F., Ahmed, E. R., & Aly, O. M. (2019). Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study. European Journal of Medicinal Chemistry, 183, 111697.
• • Özkırımlı, S., Kazan, F., & Tunalı, Y. (2009). Synthesis, antibacterial and antifungal activities of 3-(1,2,4-triazol-3- yl)-4-thiazolidinones. Journal of Enzyme Inhibition and Medicinal Chemistry, 24(2), 447–452.
• • Rollas, S., Gülerman, N., & Erdeniz, H. (2002). Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Farmaco, 57(2), 171–174.
• • Salgın-Gökşen, U., Gökhan-Kelekçi, N., Göktaş, Ö., Köysal, Y., Kılıç, E., Işık, Ş., Aktay, G. & Özalp, M. (2007). 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: Synthesis, analgesicanti-inflammatory and antimicrobial activities. Bioorganic and Medicinal Chemistry, 15(17), 5738–5751.
• • Savini, L., Chiasserini, L., Travagli, V., Pellerano, C., Novellino, E., Cosentino, S., & Pisano, M. B. (2004). New α-(N)-heterocyclichydrazones: Evaluation of anticancer, anti-HIV and antimicrobial activity. European Journal of Medicinal Chemistry, 39(2), 113–122.
• • Sztanke, K., Tuzimski, T., Rzymowska, J., Pasternak, K., & KandeferSzerszeń, M. (2008). Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives. European Journal of Medicinal Chemistry, 43(2), 404–419.
• • Tozkoparan, B., Gökhan, N., Aktay, G., Yeşilada, E., & Ertan, M. (2000). 6-Benzylidenethiazolo[3,2-b]-1,2,4-triazole-5(6H)-ones substituted with ibuprofen: Synthesis, characterization and evaluation of anti-inflammatory activity. European Journal of Medicinal Chemistry, 35(7), 743–750.
• • Turan-Zitouni, G., Kaplancıklı, Z. A., Erol, K., & Kılıç, F. S. (1999). Synthesis and analgesic activity of some triazoles and triazolothiadiazines. Farmaco, 54(4), 218–223.
• • Turan-Zitouni, G., Kaplancıklı, Z. A., Yıldız, M. T., Chevallet, P., & Kaya, D. (2005). Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H1,2,4-triazole derivatives. European Journal of Medicinal Chemistry, 40(6), 607–613.
• • Ulusoy Güzeldemirci, N., & Küçükbasmacı, Ö. (2010). Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. European Journal of Medicinal Chemistry, 45(1), 63–68.
• • Ulusoy Güzeldemirci, N., Şatana, D., & Küçükbasmacı, Ö. (2013). Synthesis, characterization, and antimicrobial evaluation of some new hydrazinecarbothioamide, 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(5), 968–973.
• • Ulusoy, N., Ateş, Ö., Küçükbasmacı, Ö., Kiraz, M., & Yemenoğlu, Y. (2003). Synthesis, Characterization, and Evaluation of Antimicrobial Activity of Some 1,2,4-Triazole Derivatives Bearing an Antipyryl Moiety. Monatshefte für Chemie, 134(3), 465–474.
• • Ulusoy, N., Ergenç, N., Ötük, G., & Kiraz, M. (2001a). Synthesis of some 4-(alkylidene/arylidene)amino-2,4-dihydro-5-(2thienyl)-3H-1,2,4-triazole-3-thiones tested for antimicrobial activity. Bollettino Chimico Farmaceutico, 140(6), 417–421.
• • Ulusoy, N., Gürsoy, A., & Ötük, G. (2001b). Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco, 56(12), 947–952.
• • Wayne, P. A. (2005). Clinical and Laboratory Standards Institute. Performance standards for antimicrobial testing, 15th informational supplement. M100-S15. Clinical and Laboratory Standards Institute.
• • Wayne, P. A. (2002a). National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-2nd Edition. M27-A2. Clinical and Laboratory Standards Institute.
• • Wayne, P. A. (2002b). National Committee for Clinical Laboratory Standards. Reference method for broth dilution an antifungal susceptibility testing filamentous fungi; Approved standard M38A2. Clinical and Laboratory Standards Institute.
• • Weng, Q., Huang, J., Zeng, Y., Deng, Y., & Hu, M. (2012). Synthesis and herbicidal activity evaluation of novel β-carboline derivatives. Molecules, 17(4), 3969–3980.
• • Završnik, D., Muratović, S., Makuc, D., Plavec, J., Cetina, M., Nagl, A., Clercq, E. D., Balzarini, J., & Mintas, M. (2011). Benzylidene-bis-(4hydroxycoumarin) and benzopyrano-coumarin derivatives: Synthesis, 1H/13C-NMR conformational and X-ray crystal structure studies and in vitro antiviral activity evaluations. Molecules, 16(7), 6023–6040.